|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:acquisition
|
gptkb:Zymergen
gptkb:Edico_Genome
gptkb:Solexa
Blue Bee
Verinata Health
|
|
gptkbp:ceo
|
gptkb:Francis_de_Souza
|
|
gptkbp:employees
|
over 7,000
|
|
gptkbp:focus
|
Personalized medicine
Genomic sequencing
Genomic research
|
|
gptkbp:founded
|
gptkb:1998
|
|
gptkbp:founder
|
gptkb:Jay_Flatley
|
|
gptkbp:headquarters
|
gptkb:San_Diego,_California
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Illumina Genomics
|
|
gptkbp:industry
|
gptkb:Company
|
|
gptkbp:market_cap
|
$50 billion (2021)
|
|
gptkbp:partnership
|
gptkb:GSK
gptkb:temple
gptkb:Johnson_&_Johnson
gptkb:Takeda_Pharmaceutical_Company
gptkb:Sanofi
gptkb:Bristol-Myers_Squibb
gptkb:Pfizer
gptkb:Regeneron_Pharmaceuticals
gptkb:Biogen
gptkb:Merck_&_Co.
gptkb:Roche
gptkb:Amgen
gptkb:Vertex_Pharmaceuticals
gptkb:GRAIL,_Inc.
gptkb:Illumina_Accelerator
gptkb:Abb_Vie
gptkb:Novartis
|
|
gptkbp:products
|
DNA sequencing systems
Genotyping systems
|
|
gptkbp:revenue
|
$3.24 billion (2020)
|
|
gptkbp:subsidiary
|
gptkb:Illumina_Cambridge_Ltd.
gptkb:Illumina_Japan_K._K.
gptkb:Illumina_Netherlands_B._V.
gptkb:Illumina_Singapore_Pte._Ltd.
Illumina Germany Gmb H.
|
|
gptkbp:symbol
|
gptkb:ILMN
|
|
gptkbp:technology
|
Next-generation sequencing
Microarray technology
Sequencing by synthesis
|
|
gptkbp:website
|
www.illumina.com
|
|
gptkbp:bfsParent
|
gptkb:Illumina
|
|
gptkbp:bfsLayer
|
4
|